Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2019-09-19 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
INTERIM REPORT 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM 2019 REPORT' and contains detailed sections such as Management Discussion and Analysis, condensed consolidated interim financial statements, and notes to the condensed consolidated interim financial statements. It covers the six months ended 30 June 2019, indicating it is a report for a period shorter than a full fiscal year. The content includes financial performance, business strategies, market review, and outlook, which are typical of an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-09-19 English
MAJOR TRANSACTION AND INSIDE INFORMATION DISPOSAL OF CBPO SHARES, ENTERING INTO THE CONSORTIUM AGREEMENT AND SUBMISSION OF THE PRELIMINARY NON-BINDING PRIVATIZATION PROPOSAL
Capital/Financing Update Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding a major transaction involving the disposal of shares in CBPO, entering into a consortium agreement, and submission of a preliminary non-binding privatization proposal. It references compliance with Hong Kong Listing Rules, details of the share purchase agreement, consortium formation, and implications for shareholders. The document is structured as a formal announcement with detailed transaction terms, conditions precedent, and regulatory references. It does not contain financial statements or comprehensive financial performance data typical of an Annual Report or Interim Report. It is not a transcript, audit report, or remuneration report. The content focuses on a major transaction and related corporate actions, consistent with a Capital/Financing Update. The length (15,000 characters) and detailed transaction information confirm it is not a brief announcement or a report publication notice. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2019-09-19 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/08/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content focuses on share capital changes and related confirmations, typical of regulatory filings required by stock exchanges to report share capital movements. It does not contain financial statements, earnings data, or management commentary. It is not an announcement of a report but a detailed monthly return on share capital movements. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2019' and contains detailed unaudited condensed consolidated interim financial statements including income statement, statement of financial position, statement of changes in equity, and cash flows for the six months ended June 30, 2019. It also includes notes to the condensed consolidated interim financial statements and references to HKAS 34, which governs interim financial reporting. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The content and structure clearly identify it as a comprehensive interim financial report for a half-year period, consistent with the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the date of a board meeting to approve and publish the unaudited consolidated interim results for the six months ended 30 June 2019. It does not contain the actual interim financial results or detailed financial data but rather informs about the upcoming board meeting and the intention to release the interim results. The document length is short (1406 characters) and serves as a notice rather than a report. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2019-08-16 English
UNAUDITED RESULTS FOR THE SECOND QUARTER AND THE FIRST HALF OF 2019 OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
Earnings Release Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding the unaudited financial results of its associate company China Biologic Products Holdings, Inc. for the second quarter and first half of 2019. It references an Earnings Release filed with the SEC and provides a summary of key financial figures from that release. The document is relatively short (4259 characters) and primarily serves to inform shareholders and investors about the associate's financial results, not to present a full financial report of PW Medtech itself. It explicitly states that the full Earnings Release is available via a link and that the information is unaudited and prepared under U.S. GAAP. This fits the profile of an Earnings Release (ER) announcement rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). Therefore, the appropriate classification is Earnings Release (ER). H1 2019
2019-08-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.